LSD Psychotherapy Stanislas GROF Hunter House Ed., 1979 LIST OF CONTENTS 1. History of LSD Therapy The Discovery of LSD and its Psychedelic Effects Early Laboratory and Clinical LSD Research Therapeutic Experimentation With LSD Studies of Chemotherapeutic Properties of LSD LSD-Assisted Psychotherapy The Need for a Comprehensive Theory of LSD Therapy 2. Critical Variables in LSD Therapy Pharmacological Effects of LSD Personality of the Subject Personality of the Therapist or Guide Set and Setting of the Sessions 3. Psycholytic and Psychedelic Therapies with LSD : Towards an Integration of Approaches The Search for an Effective Technique of LSD Psychotherapy Advantages and Drawbacks of the Psycholytic Approach Pros and Cons of Psychedelic Therapy 4. Principles of LSD Psychotherapy The Preparation Period Psychedelic Sessions Integration [...]
Lire la suitePsilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Roland R. Griffiths, William A. Richards, Una McCann, Robert Jesse Psychopharmacology, 2006 DOI 10.1007/s00213-006-0457-5 Abstract Rationale : Although psilocybin has been used for centuries for religious purposes, little is known scientifically about its acute and persisting effects. Objectives : This double-blind study evaluated the acute and longer-term psychological effects of a high dose of psilocybin relative to a comparison compound administered under comfortable, supportive conditions. Materials and methods : The participants were hallucinogennaïve adults reporting regular participation in religious or spiritual activities. Two or three sessions were conducted at 2-month intervals. Thirty volunteers [...]
Lire la suitePsilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors Roland R. Griffiths, Matthew W. Johnson, William A. Richards, Brian D. Richards3, Robert Jesse, Katherine A. MacLean, Frederick S. Barrett, Mary P. Cosimano and Maggie A. Klinedinst Journal of Psychopharmacology, 2018, 32, 1, 49-69. DOI: 10.1177/0269881117731279 Abstract Psilocybin can occasion mystical-type experiences with participant-attributed increases in well-being. However, little research has examined enduring changes in traits. This study administered psilocybin to participants who undertook a program of meditation/spiritual practices. Healthy participants were randomized to three groups (25 each): [...]
Lire la suiteMystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later Roland R. Griffiths ,W.A. Richards , Matthew W. Johnson, Una D. McCann, R. Jesse Journal of Psychopharmacology, 2008, 1–12. Doi : 10.1177/0269881108094300 Abstract Psilocybin has been used for centuries for religious purposes; however, little is known scientifically about its long-term effects. We previously reported the effects of a double-blind study evaluating the psychological effects of a high psilocybin dose. This report presents the 14-month follow-up and examines the relationship of the follow-up results to data obtained at screening and on drug session days. Participants were 36 hallucinogen-naïve adults [...]
Lire la suitePsilocybin occasioned mystical-type experiences : immediate and persisting dose-related effects Roland R. Griffiths, Matthew W. Johnson, William A. Richards, Brian D. Richards, Una McCann, Robert Jesse Psychopharmacology, 2011 DOI 10.1007/s00213-011-2358-5 Abstract Rationale : This dose-effect study extends previous observations showing that psilocybin can occasion mystical-type experiences having persisting positive effects on attitudes, mood, and behavior. Objectives : This double-blind study evaluated psilocybin (0, 5, 10, 20, 30 mg/70 kg, p.o.) administered under supportive conditions. Methods : Participants were 18 adults (17 hallucinogennaïve). Five 8-h sessions were conducted individually for each participant at 1-month intervals. Participants were randomized to receive the four active doses in either ascending or [...]
Lire la suiteHallucinogens and redemption Marlene Dobkin de Rios, Charles S Grob, John R Baker Journal of Psychoactive Drugs, 2002, 34, 3, 239-248. Abstract : This article examines drug substitution with regard to hallucinogens (ayahuasca, ibogaine, peyote and LSD) set within the concept of redemption. The model examines both religious and secular approaches to the contemporary use of hallucinogens in drug substitution, both by scientists and in religious setting worlwide. The redemptive model posits that the proper use of one psychoactive substance within a spiritual or clinical context helpsto free an individual from the adverse effects of their addiction to another substance and thus restores them [...]
Lire la suite